Randomized Clinical Trial
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 14, 2017; 23(34): 6357-6364
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6357
Table 3 General risk factors for pancreatic leakage
VariablePOPF (n = 14)Non-POPF (n = 26)t/z/χ2P value
Age in yr54.18 ± 6.94554.04 ± 10.4470.0650.948
Sex
Male20 (71.4)32 (58.2)1.3910.3371
Female8 (28.6)23 (41.8)
Blood loss in mL300 (200, 575)200 (200, 600)-1.2660.205
Pancreatic duct diameter in mm
> 311 (39.3)33 (60.0)3.1960.1041
< 317 (60.7)22 (40.0)
Preoperative low plasma protein
Yes7 (25.0)12 (21.8)0.1060.7861
No21 (75.0)43 (78.2)
Preoperative relief of jaundice
Yes4 (14.3)4 (7.3)1.0480.4331
No24(85.7)51 (92.7)
Preoperative jaundice
Yes18 (64.3)34 (61.8)0.0481.000
No10 (35.7)21 (38.2)
Surgical type
External drainage of PD12 (42.9)27 (49.1)0.2890.6471
Internal drainage of PD16 (57.1)28 (50.9)
Diabetes
Yes2 (7.1)0 (0.0)4.0260.1111
No26 (92.9)55 (100.0)
Duration of surgery in min267.5 (240.0, 327.5)280.0 (235.0, 335.0)-0.0820.935
Hospitalization period in days15.00 (13.00, 18.00)21.50 (18.00, 27.75)-4.385< 0.001
Drainage fluid amylase level on POD1 in U/L6017.5 (2494.5, 11752.5)890.0 (350.0, 1500.0)-5.110< 0.001
Serum amylase level in U/L
POD1379.5 (157.5, 627.5)124.0 (80.0, 165.0)-4.091< 0.001
POD430.0 (30.0, 50.0)61.5 (45.5, 150.0)-4.435< 0.001
Serum albumin
POD129.5 (25.3, 34.3)30.7 (26.6, 33.0)-0.1250.900
POD330.1 (25.7, 34.6)30.4 (27.1, 33.2)-0.1110.912
POD530.8 (27.8, 34.4)31.4 (28.4, 36.9)-0.7180.473
Choline
POD14957 (4022, 4957)5242 (4048, 6715)-0.8760.381
POD33481 (2626, 4518)4056 (3345, 5020)-1.4250.154
POD53268 (2696, 4537)4024 (3248, 5069)-1.5800.114
WBC count
POD114.73 (10.84, 18.75)15.49 (12.42, 18.41)-0.7510.452
POD314.90 (11.74, 18.64)13.54 (10.34, 16.58)-1.1120.266
POD511.99 (9.65, 15.56)11.24 (9.17, 14.79)-0.5100.610
Pathology examination result2.4450.485
Cholangiocarcinoma12 (42.9)29 (52.7)
Pancreatic carcinoma3 (10.7)8 (14.5)
Ampullary carcinoma3 (10.7)7 (12.7)
Other10 (35.7)11 (20.0)